BYBEE CLINTON — SEC insider filings

SEC reporting owner CIK 1219043. 38 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2020-09-22 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lyell Immunopharma, Inc. (LYEL)10% owner42 legs · 2,809,352 sh · $37,499,977—6
Neumora Therapeutics, Inc. (NMRA)10% owner32 legs · 3,415,700 sh · $30,499,977—12
Codiak BioSciences, Inc. (CDAK)10% owner22 legs · 5,235,000 sh · $11,025,000—11
Sana Biotechnology, Inc. (SANA)10% owner23 legs · 1,818,181 sh · $9,999,996—14
908 Devices Inc. (MASS)10% owner11 leg · 300,000 sh · $6,000,000—6
Boundless Bio, Inc. (BOLD)10% owner22 legs · 200,000 sh · $3,200,0001 leg · 16,000 sh · $39,84012
Metacrine, Inc. (MTCR)10% owner12 legs · 230,000 sh · $2,990,000—8
Vir Biotechnology, Inc. (VIR)10% owner14——95
Beam Therapeutics Inc. (BEAM)10% owner4——27
Karuna Therapeutics, Inc. (KRTX)10% owner3——12

+2 more issuers among the filings shown — every filing appears in the table below.

Insider filings — BYBEE CLINTON

FiledFormIssuerReported transactionsSource
2026-11-054Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT, Burow Kristina, BERNS PAUL L
Purchase (P): 2,321,262 @ $10.77EDGAR
2026-07-064Boundless Bio, Inc. (BOLD)
jointly with CRANDELL KEITH, NELSEN ROBERT, GILLIS STEVEN, Burow Kristina
Option exercise (M): 16,000 @ $1.03 · Sale (S): 16,000 @ $2.49 · Option exercise (M): 16,000 (derivative) @ $0EDGAR
2026-03-094Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Fund XIII, L.P., ARCH Venture Partners XIII, L.P., ARCH Venture Partners XIII, LLC, CRANDELL KEITH, NELSEN ROBERT, Burow Kristina, GILLIS STEVEN, BERNS PAUL L
Purchase (P): 488,090 @ $25.61EDGAR
2025-10-294Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Purchase (P): 1,915,700 @ $2.61EDGAR
2025-07-294Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, NELSEN ROBERT
Holdings only — no transactions reportedEDGAR
2024-04-044Boundless Bio, Inc. (BOLD)
jointly with CRANDELL KEITH, NELSEN ROBERT, GILLIS STEVEN
Conversion (C): 589,743 · Conversion (C): 787,545 · Conversion (C): 1,048,433 · Purchase (P): 66,667 @ $16 · Purchase (P): 133,333 @ $16 · Conversion (C): 424,908 (derivative) · +6 moreEDGAR
2024-02-124Sana Biotechnology, Inc. (SANA)
jointly with CRANDELL KEITH, Burow Kristina, GILLIS STEVEN
Purchase (P): 363,637 @ $5.50 · Purchase (P): 727,272 @ $5.50 · Purchase (P): 727,272 @ $5.50EDGAR
2023-12-124Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Other (J): 703,061 · Other (J): 1,176,593EDGAR
2023-09-204Neumora Therapeutics, Inc. (NMRA)
jointly with ARCH Venture Partners X, LLC, ARCH Venture Partners XII, LLC, ARCH Venture Partners XII, L.P., ARCH Venture Fund XII, L.P., CRANDELL KEITH, GILLIS STEVEN, NELSEN ROBERT
Conversion (C): 684,167 · Conversion (C): 1,144,973 · Conversion (C): 6,895,021 · Conversion (C): 6,576,400 · Conversion (C): 2,124,143 · Purchase (P): 1,500,000 @ $17 · +5 moreEDGAR
2022-09-154Codiak BioSciences, Inc. (CDAK)
jointly with ARCH Venture Fund VIII, L.P., ARCH Venture Fund VIII Overage, L.P., CRANDELL KEITH, NELSEN ROBERT, ARCH Venture Partners VIII, LLC, ARCH Venture Partners VIII, L.P.
Purchase (P): 5,000,000 @ $1.50 · Purchase (P): 5,000,000 (derivative)EDGAR
2022-09-074Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 196,003 @ $0 · Other (J): 253,997 @ $0 · Other (J): 11,763 @ $0 · Other (J): 1,338 @ $0 · Other (J): 2,662 @ $0 · Other (J): 239,559 @ $0 · +4 moreEDGAR
2022-09-014Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0 · Other (J): 217,781 @ $0 · +4 moreEDGAR
2022-08-264Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0 · Other (J): 217,781 @ $0 · +4 moreEDGAR
2022-08-224Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0EDGAR
2022-08-164Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0 · Other (J): 217,781 @ $0 · +9 moreEDGAR
2022-06-104Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 1,475 @ $0 · Other (J): 2,952 @ $0EDGAR
2022-06-064Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,076 @ $0 · Other (J): 4,426 @ $0EDGAR
2021-12-224Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 762,233 @ $0 · Other (J): 987,767 @ $0 · Other (J): 45,703 @ $0 · Other (J): 15,504 @ $0EDGAR
2021-12-014Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,057 @ $0 · Other (J): 4,428 @ $0EDGAR
2021-11-244Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 13,057 @ $0 · Other (J): 4,428 @ $0EDGAR
2021-07-064Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 1,742,248 @ $0 · Other (J): 2,257,752 @ $0 · Other (J): 25,279 @ $0 · Other (J): 8,133 @ $0EDGAR
2021-07-024Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, NELSEN ROBERT
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,555 @ $0 · Other (J): 811 @ $0 · Other (J): 4,686 @ $0EDGAR
2021-06-294Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH, NELSEN ROBERT
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,555 @ $0 · Other (J): 811 @ $0 · Other (J): 4,686 @ $0 · Other (J): 200,000 @ $0 · +4 moreEDGAR
2021-06-244Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 435,562 @ $0 · Other (J): 564,438 @ $0 · Other (J): 6,320 @ $0 · Other (J): 2,028 @ $0EDGAR
2021-06-234Lyell Immunopharma, Inc. (LYEL)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Fund IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Partners IX, L.P., CRANDELL KEITH
Conversion (C): 18,206,358 · Conversion (C): 18,206,358 · Conversion (C): 17,771,216 (derivative) @ $0 · Conversion (C): 17,771,216 (derivative) @ $0 · Conversion (C): 435,142 (derivative) @ $0 · Conversion (C): 435,142 (derivative) @ $0EDGAR
2021-04-154Karuna Therapeutics, Inc. (KRTX)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 75,000 @ $0 · Other (J): 75,000 @ $0 · Other (J): 958 @ $0 · Other (J): 306 @ $0EDGAR
2021-04-094Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 3,161 @ $0 · Other (J): 1,019 @ $0 · Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · +2 moreEDGAR
2021-04-024Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,555 @ $0 · Other (J): 811 @ $0EDGAR
2021-04-014Vir Biotechnology, Inc. (VIR)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · Other (J): 3,160 @ $0 · Other (J): 1,014 @ $0 · Other (J): 217,781 @ $0 · Other (J): 282,219 @ $0 · +2 moreEDGAR
2021-03-224Beam Therapeutics Inc. (BEAM)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · Other (J): 2,553 @ $0 · Other (J): 810 @ $0 · Other (J): 200,000 @ $0 · Other (J): 200,000 @ $0 · +2 moreEDGAR
2021-02-104Sana Biotechnology, Inc. (SANA)
jointly with ARCH Venture Fund X, L.P., CRANDELL KEITH, Burow Kristina, GILLIS STEVEN
Conversion (C): 10,156,250 · Conversion (C): 10,156,250 · Conversion (C): 11,718,750 · Conversion (C): 11,718,750 · Conversion (C): 3,687,500 (derivative) @ $0 · Conversion (C): 3,687,500 (derivative) @ $0 · +8 moreEDGAR
2021-01-124Karuna Therapeutics, Inc. (KRTX)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 75,000 @ $0 · Other (J): 75,000 @ $0 · Other (J): 958 @ $0 · Other (J): 306 @ $0EDGAR
2020-12-224908 Devices Inc. (MASS)
jointly with ARCH Venture Fund VII, L.P., ARCH Venture Partners VII, L.P., ARCH Venture Partners VII, LLC, NELSEN ROBERT
Conversion (C): 5,425,045 · Purchase (P): 300,000 @ $20 · Conversion (C): 2,927,386 (derivative) @ $0 · Conversion (C): 981,443 (derivative) @ $0 · Conversion (C): 669,977 (derivative) @ $0 · Conversion (C): 665,661 (derivative) @ $0 · +1 moreEDGAR
2020-11-244Quanterix Corp (QTRX)
jointly with ARCH VENTURE FUND VI LP, ARCH Venture Fund VIII Overage, L.P., ARCH VENTURE PARTNERS VI LP, ARCH VENTURE PARTNERS VI LLC, ARCH Venture Partners VIII, LLC, NELSEN ROBERT
Other (J): 229,006 @ $0 · Other (J): 145,994 @ $0 · Other (J): 854 @ $0 · Other (J): 853 @ $0 · Other (J): 277,514 @ $0 · Other (J): 176,920 @ $0 · +2 moreEDGAR
2020-11-164Karuna Therapeutics, Inc. (KRTX)
jointly with ARCH Venture Partners IX, LLC, ARCH Venture Partners IX, L.P., ARCH Venture Partners IX Overage, L.P., ARCH Venture Fund IX, L.P., ARCH Venture Fund IX Overage, L.P., CRANDELL KEITH
Other (J): 75,000 @ $0 · Other (J): 75,000 @ $0 · Other (J): 958 @ $0 · Other (J): 306 @ $0EDGAR
2020-10-234IMPINJ INC (PI)Option exercise (M): 3,411 @ $0 · Option exercise (M): 3,411 (derivative) @ $0EDGAR
2020-10-204Codiak BioSciences, Inc. (CDAK)
jointly with ARCH Venture Fund VIII, L.P., ARCH Venture Fund VIII Overage, L.P., CRANDELL KEITH, NELSEN ROBERT, ARCH Venture Partners VIII, LLC, ARCH Venture Partners VIII, L.P.
Conversion (C): 1,784,572 · Conversion (C): 831,521 · Conversion (C): 420,368 · Conversion (C): 326,953 · Conversion (C): 191,721 · Purchase (P): 235,000 @ $15 · +5 moreEDGAR
2020-09-224Metacrine, Inc. (MTCR)
jointly with ARCH Venture Fund VIII, L.P., ARCH Venture Fund VIII Overage, L.P., CRANDELL KEITH, NELSEN ROBERT, ARCH Venture Partners VIII, LLC, ARCH Venture Partners VIII, L.P.
Conversion (C): 1,960,784 · Conversion (C): 472,251 · Conversion (C): 138,734 · Purchase (P): 210,000 @ $13 · Conversion (C): 138,734 · Purchase (P): 20,000 @ $13 · +4 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1219043 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs